Malaga Cove Capital’s GoodRx Holdings GDRX Stock Holding History

Malaga Cove Capital’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-16,517	Closed	-$319K	–	167
2022 Q1	$319K	Buy	+16,517	New	+$379K	0.15%	145
2021 Q2	–	Sell	-11,019	Closed	-$430K	–	155
2021 Q1	$430K	Buy	11,019 +125	+1%	+$5.62K	0.18%	140
2020 Q4	$448K	Buy	+10,894	New	+$500K	0.21%	134

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Malaga Cove Capital's GDRX Position: Q2 2022 in Review

Malaga Cove Capital sold out of GoodRx Holdings (GDRX) in Q2 2022, closing a stake of 16,517 shares — an estimated $319K sold.

Malaga Cove Capital first reported a position in GDRX in Q4 2020 and held it in 3 quarters. The position peaked at $448K in Q4 2020. 174 funds tracked by Wall St. Rank hold GDRX as of Q2 2022.

Malaga Cove Capital reported no remaining GoodRx Holdings position as of Q2 2022 after selling out during the quarter.
Malaga Cove Capital sold 16,517 GoodRx Holdings shares in Q2 2022, an estimated $319K.
Malaga Cove Capital first reported a position in GoodRx Holdings in Q4 2020 and held it in 3 quarters.
Malaga Cove Capital's GoodRx Holdings position peaked at $448K in Q4 2020.
174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2022.

Based on Malaga Cove Capital's 13F filing for Q2 2022, filed 2 Aug 2022.